Visaline in the treatment of age-related macular degeneration: a pilot study.

Abstract	Age-related macular degeneration (AMD) is the main cause of a reduction in visual acuity in patients over the age of 65 years. A positive influence of medical treatment (i.e. with vitamins and trace minerals) has been suggested but remains unproven. In this randomized, double-blind study, 20 patients in an early stage of AMD were included. Over a period of 6 months, 9 patients were treated with Visaline and 11 with a placebo. The effect of the treatment was not statistically different between the two groups, admittedly small in number, in terms of visual and retinal acuity, color vision, and contrast sensitivity. Despite the lack of such measureable differences, the patients' own subjective assessments, however, were much better in the Visaline-treated group. Due to the short duration of the observation time, we can not comment on a possible long-term effect.
Authors	H J Kaiser, J Flammer, D Stümpfig, P Hendrickson
Journal	Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde (Ophthalmologica) Vol. 209 Issue 6 Pg. 302-5 ( 1995) ISSN: 0030-3755 [Print] Switzerland
PMID	8751336 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References	Adrenergic beta-Agonists Antioxidants Drug Combinations Tablets alpha tocopherol, ascorbic acid, betacarotene, buphenine hydrochloride drug combination beta Carotene Vitamin E Nylidrin alpha-Tocopherol Ascorbic Acid Tocopherols
Topics	Adrenergic beta-Agonists (therapeutic use) Aged Antioxidants (therapeutic use) Ascorbic Acid (therapeutic use) Double-Blind Method Drug Combinations Female Humans Intraocular Pressure Macular Degeneration (drug therapy, physiopathology) Male Nylidrin (therapeutic use) Pilot Projects Tablets Tocopherols Vision, Ocular (physiology) Visual Acuity Vitamin E (analogs & derivatives, therapeutic use) alpha-Tocopherol (analogs & derivatives) beta Carotene (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!